Clinical Trial Update: rhTPO Dose Escalation vs Eltrombopag Switch in ITP [NA]

View source ↗

Summary

Clinical trial comparing rhTPO dose escalation versus switching to eltrombopag in patients with primary immune thrombocytopenia. The study is currently not yet …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune Thrombocytopenia

Drugs mentioned

• Eltrombopag (eltrombopag)
• rhTPO (recombinant human thrombopoietin)

Snippet

Sponsor: Institute of Hematology & Blood Diseases Hospital, China | Conditions: Primary Immune Thrombocytopenia (ITP) | NA | Status: NOT_YET_RECRUITING